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Abstract
Lead, a chemical element in the carbon group with symbol Pb (from Latin: Plumbum, meaning “the liquid silver”) and has 
an atomic number 82 in the periodic table. It was the first element that was characterized by its kind of toxicity. In animal 
systems, lead (Pb) has been incriminated in a wide spectrum of toxic effects and it is considered one of the persistent 
ubiquitous heavy metals. Being exposed to this metal could lead to the change of testicular functions in human beings 
as well as in the wildlife. The lead poising is a real threat to the public health, especially in the developing countries. 
Accordingly, great efforts on the part of the occupational and public health have been taken to curb the dangers of this 
metal. Hematopoietic, renal, reproductive, and central nervous system are among the parts of the human body and systems 
that are vulnerable toward the dangers following exposure to high level of Pb. In this review, we discussed the massive 
harmful impact that leads acetate toxicity has on the animals and the worrying fact that this harmful toxicant can be found 
quite easily in the environment and abundance. Highlighting its (Pb) effects on various organs in the biological systems, its 
economic, as well as scientific importance, with the view to educate the public/professionals who work in this area. In this 
study, we focus on the current studies and research related to lead toxicity in animals and also to a certain extent toward 
human as well.
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Introduction
Lead is considered as one of the most hazards 
and cumulative environmental pollutants that affect 
all biological systems through exposure to air, water, 
and food sources [1]. The exposure to lead induces 
clinic pathological changes through toxicity occurring 
in kidney and endocrine system [2]. A high level of 
lead in animals resulted in reproductive failure [3]. 
Lead is one of the global environmental pollutants, 
mainly found widely in industrial regions, as such that 
animals can easily be exposed to lead. Lead poison-
ing particularly in animals can be found from numer-
ous sources in the general environment, and this can 
be traced back from contamination of feed, and soil 
from industrial pollution and agricultural practices. 
Furthermore, consuming high amount of lead has 
resulted in poor performance, poisoning, and death in 
animals [4,5]. Accumulated lead is toxic in most of its 
chemical forms, whether it is inhaled or ingested in 
water or feed. The extent to which orally administered 
lead absorbed into the host is small. However, due 
to its slow rate of elimination, harmful levels of lead 
can accumulate in tissues after prolonged exposure to 
low quantities [6]. Lead is a heavy metal that is both 
poisonous and a ubiquitous environmental toxicant. It 
is distributed in all parts of the environment in three 
main forms: Metallic lead, lead salts, and organic lead 
containing carbon [7,8]. The major sources of occu-
pational lead exposure are traditionally leaded gaso-
line, lead-based paints, and batteries. Lead exposure 
has been a widely recognized as a significant public 
health problem over recent decades, and high levels of 
occupational lead contact are now strictly controlled 
due to their adverse health effects. However, envi-
ronmental lead exposure such as that in domestic tap 
water, food-borne contamination, and household dust 
continue to pollute our surroundings in daily life [9]. 
Exposure to lead is considered to be detrimental 
and associated with behavioral abnormalities, hear-
ing deficits, neuromuscular weakness, and impaired 
cognitive functions in humans and experimental ani-
mals [10]. Indeed, no blood-lead levels appeared to be 
safe, and sub-clinical influences of lead toxicity were 
reported in recent years [11]. This is attributed to the 
induction of oxidative stress by elevation of reactive 
oxygen species (ROS) like lipid peroxides, hydroxyl 
radicals and hydrogen peroxide and superoxide radi-
cals [12]. In mammals, ROS is generated either by the 
Copyright: Assi, et al. Open Access. This article is distributed under 
the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which 
permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original 
author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons 
Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this 
article, unless otherwise stated.
Veterinary World, EISSN: 2231-0916 661
Available at www.veterinaryworld.org/Vol.9/June-2016/20.pdf
mitochondrial electron transport chain or nicotinamide 
adenine dinucleotide phosphate oxidase in virtually 
all cell types and is involved in regulating cell prolif-
eration and differentiation, and genomic stability [13]. 
However, increased ROS production occurs in numer-
ous pathologic situations including hematopoietic 
stem cell (HSC) apoptosis and premature senescence. 
The oxidative stress role in the lead-exposure-in-
duced HSC function remains unclear [14]. There are 
about 40 heavy metals which are capable of combin-
ing with a wide variety of organic molecules and are 
potent enzyme inhibitors because of their interaction 
with ligands present in proteins, and they inactivate 
the enzyme system of cell [15]. The removal of lead 
from gasoline has resulted in decreased exposure in 
many countries. However, because of its malleability, 
resistance to corrosion, and low melting point, lead 
has been widely used in industries and levels remain 
high in many areas [16].
The significance of the review is mainly due to 
the harmful effects of lead acetate toxicity has on the 
animals and its (Pb) abundance in the environment. 
Therefore, it is warranted for the review to be writ-
ten to address this matter thus preventing more occur-
rence of lead toxicity and notably to highlight the 
effects lead toxicoses on animal husbandry economics 
and science.
The aim of this review paper is to educate the peo-
ple who work closely with animals such as veterinarians, 
researchers, animal practitioners, and others regarding 
the detrimental effects of lead toward the health and 
well-being of the animal’s particularly food-producing 
animals. This elaborated review focuses on the current 
investigations related to lead toxicity.
Lead Effects on Various Organs
Lead, which affects many cellular processes and 
enzyme systems all over the body, has different pos-
sible mechanisms of action. Most research on lead 
poisoning focuses more on its toxicity effects on the 
hematology, cardiovascular, renal, and neurotoxicities 
with the emphasis toward the neurological effects of 
lead poisoning. Yet, the other areas of concern were 
also plentiful from this research [17]. At a theoreti-
cal level, mechanisms of lead toxicity on the repro-
ductive system of male were not yet fully explained. 
Numerous pathways are possible to clarify how expo-
sure to lead could decrease fertility in male. For exam-
ple, multiple potassium and calcium channel isoforms 
in human spermatozoa and testes might be contrib-
uted in the earlier activities of acrosome reaction [18]. 
Moreover, in lead-exposed rats’ reproductive organs, 
activities of some enzymes, such as sodium potas-
sium ATPase and alkaline phosphatase (ALP), were 
shown to be decreased [19]. An additional issue in 
reproductive toxicity of lead may have a relation with 
the excessive generation of ROS, an issue that was 
recently given much attention. Sulfhydryl antioxi-
dants production is inhibited by ROS, which damages 
nucleic acids, inhibits the repair of DNA and inhib-
its reactions of enzyme, and also inhibits the per-
oxidation of initiating lipid in cellular membranes. 
Oxidative stress is induced by lead, which encourages 
the hydrogen peroxide generation [20]. The negative 
wide-ranging of effects, because of a raise in the lev-
els of ROS in tissues, were assumed as a major dis-
orders contributor which relates to the exposure to 
lead [21]. An epidemiological study of the male repro-
ductive system has demonstrated positive correlations 
between seminal plasma lead and spermatozoa ROS 
levels [22]. Alternatively, increased activity of super-
oxide dismutase (SOD) was observed in people with 
prolonged lead exposure and it proposes a mechanism 
to the increasing of ROS production which is caused 
by exposure to lead [23]. This might be resulted in 
oxidative cell in reproductive tissues damage which is 
closely related to the production of ROS. For instance, 
research on the sperm of rats under ROS exposure in 
vitro decreased the rate of penetration in the zona-in-
tact ova and showed an early acrosome reaction [24]. 
Nevertheless, lead-induced oxidative stress has differ-
ent responses from low to high doses in numerous tar-
get sites, in addition to sperm [25]. Further evidence 
of animals that have been chronically exposed to lead 
was a rise on lipid peroxide concentration in the repro-
ductive organs [26]. Therefore, some studies have 
proposed that increased ROS production induced by 
lead is a significant molecular mechanism for the dis-
order in reproduction in male during spermatogenesis 
or in the hormonal stages. ROS are the by-products 
of many degenerative reactions in many tissues. They 
will affect the regular metabolism and damage the 
cellular components, because this molecule has one 
or more unpaired electrons, making it highly reactive 
with other molecules. ROS can damage cell structures 
of those of carbohydrates, nucleic acids, lipids, and 
proteins and alter their functions and destroy the liv-
ing cells. The shift in the balance between oxidants 
and antioxidants in favor of oxidants was termed “oxi-
dative stress” [27]. The ability of lead for the produc-
tion of ROS result in DNA strand breaks and replace 
zinc in DNA binding proteins [28]. Accordingly, inter-
est has recently grown in the role and usage of natural 
antioxidants like fruits and vegetables as a strategy to 
prevent oxidative damage in various health disorders 
with oxidative stress [29]. The toxicity effects of lead 
acetate are confirmed by previous study of Elgawish 
and Abdelrazek [30] that suggested SOD was reduced 
in lead acetate-treated rats compared to the other 
groups. The lead is reported to cause oxidative stress 
by generating the release of ROS such as superoxide 
radicals, hydrogen peroxide and hydroxyl radicals, 
and lipid peroxides. There has been increased interest 
among phytotherapists to use medicinal plants with 
antioxidant activity for protection against heavy metal 
toxicity [31].
Lead intervenes with the endogenous develop-
ment of opiate system [32]. Many toxic properties of 
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lead are due to its ability to mimic or compete with 
calcium. At picomolar concentrations, lead com-
petes successfully with calcium for binding sites on 
the cerebellar phosphokinase C and thereby affects 
neuronal signaling [33]. Lead has a binary impact on 
neurotransmitter release: Spontaneous neurotransmit-
ter release is enhanced, whereas stimulated release is 
inhibited [34]. The synthetic pathway of the heme is 
also considered as one of the target sites for lead tox-
icity. Delta aminolevulinic acid dehydratase (ALAD) 
has a high sensitivity to lead. Yet, the inhibition of 
this enzyme seems to be found in the increasing in 
circulating ALA, which is known as a weak gam-
ma-aminobutyric acid (GABA) agonist which reduces 
the releasing of GABA via presynaptic inhibition. 
Increased in circulating ALA might be the reason 
behind the observation of some disorders in behav-
ior noticed in patients with porphyria and maybe in 
toxicity of lead. Behavioral alterations which are sec-
ondary to exposure to lead in primates and rodents are 
similar to those in human. A study revealed monkeys 
that consumed food containing lead acetate from birth 
to 200 days of age have reached level from 3 to 25 ¹g/
dl of lead in blood. At the age from 7 to 8 years, they 
have been given a test of late alternation, in which the 
critical positive stimulus was alternated, and hence, 
treated monkeys exhibited less learning ability, mainly 
at longer delay intervals [35]. In the population, con-
tact to lead arises mainly through the oral route, while 
the industrial contact is mainly through inhalation. 
Lead has the same toxicity unrelated of access method 
into the body; therefore, the toxicological data would 
not depend on the route of exposure [17]. According to 
many laboratory experiments on animals, the lead has 
an extensive range of toxic influences through differ-
ent systems of an organ. However, lead may influence 
the gastrointestinal (GI), cardiovascular, immune, 
hemolymphatic, reproductive, urinary, and nervous 
systems and also cause tumors in laboratory animals. 
The most significant studies relating to the level of 
lead produced in the blood to the oral dose. In male 
rats, Chowdhury et al. [36] detected that the sperm 
counts, with levels of lead of 72 μg/dL in blood, were 
reduced. However, there were no significant effects 
in male rats, which had levels of 54 μg/dL of lead in 
blood. In female rats, which had levels of 30 μg/dL 
of lead in blood, they have unbalanced estrus cycles. 
Ovarian follicular cysts have been resulted in female 
rats that had lead levels of 53 μg/dL in blood. In male 
rats that had levels of 19 μg/dL of lead in blood, the 
prostate weight was significantly increased. In addi-
tion, a testicular damage in male rats which had levels 
of 30 μg/dL of lead in blood was detected. Davidovics 
and DiCicco-Bloom [37] stated an in vitro changes 
valuation to mammalian neurogenesis via a model of 
well-characterized cortical precursor following expo-
sure to lead. In rat’s kidney, an influence of lead on 
lipid peroxidation, renal function, and expression of 
heme oxidation was evaluated by Vargas et al. [38]. 
As stated by Qian et al. [39], the production of glu-
cose-regulated protein 78 (GRP78) in a protecting 
response to lead was raised. Researchers presented cul-
tured C6 glioma cells in rat, a cell line of astroglia-like, 
to lead acetate of 1 μ for a week. They found that the 
intracellular levels of two proteins were increased; of 
which, one has been GRP78. Regarding the GRP78, 
an accumulation started within 24 h and proceeded 
during the exposure time. Free radical-induced dam-
age caused by Pb and Cd is accomplished by two 
independent but related mechanisms [40]. Another 
mechanism for Pb- and Cd-induced oxidative stress 
is their effect on the antioxidative defense system of 
cells. Pb and Cd have a high affinity for —SH groups 
in enzymes of the antioxidative defense system such 
as glucose-6-phosphate dehydrogenase (G6PD), glu-
tathione (GSH) peroxidase (GPx), catalase (CAT) and 
SOD, and subsequently, inhibit their activity [40-42]. 
In all rats treated with lead, no major differences were 
observed in the absolute liver weights. Alternatively, 
the comparative liver weights have been considerably 
raised in animals which were exposed to the highest 
concentration of PbAc (p<0.05) comparing to the con-
trol group. Lead toxicity caused a significant increase 
in serum alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) activities, and a significant 
decrease in total serum protein as compared to their 
corresponding controls [43].
Lead Effects on Cardiovascular System
For cardiovascular changes, important neural and 
hormonal systems were affected by lead. These sys-
tems donate to the rule of the resistance of peripheral 
vascular, cardiac output, and heart rate [44]. Vascular 
smooth muscle might be directly affected by lead 
via constraining the activity of Na-K-ATPase, with a 
related raise of the levels of intracellular calcium [45]. 
Lead was also found to affect blood pressure. Bagchi 
and Preuss [46] stated that the systemic blood pressure 
in young Sprague-Dawley rats have changed and bone 
mineral density have decreased after exposure to 1% 
of lead acetate for 40 days in the drinking water. After 
treatment continued, systemic levels of blood pres-
sure were raised high and eventually returned to nor-
mal. However, after several months of lead exposure 
ends, it rises again above the accepted levels. In rats, 
lead-induced hypertension was related to nitric oxide 
reduction that is involved in (1) down-regulation of 
the soluble enzyme guanylate cyclase which gives 
cyclic guanosine monophosphate (a nitric oxide-in-
duced vasodilation mediator); (2) regulating blood 
pressure; (3) adrenergic system changes (i.e., raised 
in plasma norepinephrine, reduced the density of vas-
cular β-adrenergic receptor, and raised the activity of 
central sympathetic nervous system) [17].
Acute and chronic lead poisoning contributes in 
vascular and cardiac damage as well as possible fatal 
consequences such as cardiovascular illnesses and 
hypertension [47]. Exposure to low level of lead may 
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cause hypertension in both humans and animals [48]. 
Cerebrovascular accidents, peripheral vascular disease 
and ischemic coronary heart disease may also be con-
sidered as major disorders. Although indication of caus-
ative relationship of hypertension and exposure to lead 
was specified, it is only applied in cardiovascular out-
comes cases of toxicity of lead [47]. In animals, effects 
of cardiovascular following lead exposure were recently 
studied by Vaziri and Sica [44]. Kilikdar et al. [49] 
showed that the rats when receiving (15 mg/kg BW) 
of lead acetate cause heart damage was clearly evident 
from increased activities of serum glutamate oxaloace-
tate transaminase and lactate dehydrogenase.
Lead Effects on Kidney and Liver
Exposure by the high level of lead (>60 μg/dL) 
may cause renal dysfunction. Even a low level of 
lead (~10 μg/dL) may also provide the same prob-
lem [50]. There are two types of abnormality in renal 
functionality: Acute and chronic nephropathy. Acute 
nephropathy can be categorized morphologically via 
the degenerative changes present in the tubular epithe-
lium accompanied by the presence of nuclear enclo-
sure bodies, which contain lead protein complexes, 
and functionally via a mechanism of impaired tubular 
transport. Yet, it is not the reason behind the appear-
ance of protein in the urine but it could increase a non-
standard secretion of amino acids, phosphates, and glu-
cose, a mixture mentioned to as Fanconi’s syndrome. 
However, chronic nephropathy is much simpler and 
may cause irreversible morphological and functional 
changes. However, it is categorized by tubulointer-
stitial and glomerular variations, resulting in hyper-
uricemia, hypertension and renal breakdown [51]. 
Carmignani et al. [52] stated in his review that the 
pathological influence of the exposure of lead on the 
renal systems of both men and animals seems to result 
to the renal toxicity development under the influence 
of the oxidative stress that it causes. However, the pre-
vious study suggested that such effect only damages 
kidney in chronic exposure that becomes clinically 
significant, and that kidney damage does not usually 
occur in asymptomatic/acute cases.
Literature data on the effects of acute Pb expo-
sure triggering oxidative stress in the kidney of ani-
mals are rare. The administration of lead acetate 
showed a significant (p<0.05) increase in urea and 
creatinine concentration compared with other 
groups [53]. Sharma and Singh [54] have recently 
reported that 24 h exposure to 10 and 150 mg/kg BW 
of Pb acetate induced increased in renal thiobarbituric 
acid reactive substances (TBARS) content that acts as 
an indicator of lipid peroxidation, as well as SOD and 
CAT activities in kidney of Balb-c mice. Several 
authors have also confirmed that there were increased 
in lipid peroxidation in the kidneys of Pb-exposed ani-
mals. Studies have indicated that intraperitoneal (IP) 
injection of 20 mg/kg BW of Pb-acetate for 5 days and 
IP administration of 5 mg/kg BW of Pb acetate for a 
period of 30-day could induce increased in renal lipid 
peroxidation [55,56]. These findings are in agreement 
with Sharma et al. [57] who reported a significant 
increase in the level of renal TBARS in rats treated 
orally for 40 days with Pb-nitrate at a dose of 
50 mg/kg BW as well as with the results of Wang 
et al. [16] who demonstrated lipid peroxidation 
enhancement as measured by the levels of malondial-
dehyde (MDA) in the kidney of rats exposed to 
500 mg Pb/L via drinking water for 8 weeks. Recent 
investigations performed on mice [54,58] also showed 
that prolonged Pb exposure induced generation of free 
radicals and lipid peroxidation in the kidney, subse-
quent loss of membrane integrity and inactivation of 
tubular cell constituents. Most of the authors agreed 
that Pb produced lipid peroxidation mainly via ROS 
generation such as H2O2 and OH, although experi-
mental data indicate the involvement of nitrogen spe-
cies as well. This is supported by a study that showed 
IP injection of Pb-acetate (20 mg/kg BW) for 5 days 
induced an elevation of renal NO as a result of 
increased activity of inducible NO synthase [55]. 
Enhanced levels of ROS can also be attributed to 
Pb-induced disruptions in the antioxidant defense sys-
tem. Several studies have shown that Pb alters the 
activity of antioxidant enzymes such as SOD, CAT, 
GPx, GST, and G6PD as well as the content of GSH in 
animals and humans. Which means that prolonged IP 
or oral Pb exposure in experimental studies induced 
significant decrease in the activity of antioxidant 
enzymes in renal tissues [16,55,56]. Mechanisms of 
Pb effects on these enzymes can be complex, since Pb 
can competitively inhibit bio-elements absorption 
and/or replace them in the active sites of enzymes or 
bind to — SH groups of proteins [16,56]. In addition 
to oxidative stress as mechanism of Pb toxicity in the 
kidney, the experimental studies have shown that Pb 
exposure induces an increase in apoptosis not only in 
liver but also in kidneys as well [59]. Has demon-
strated that chronic treatment of rats with Pb-acetate 
over a period of 12-week increased the number of 
apoptotic bodies in the proximal tubular cells. Thus, it 
can be hypothesized that Pb intoxication influences 
gene expression of apoptosis proteins. After absorp-
tion, lead is passed to many tissues in the body. It 
causes basophilic stippling in blood because of its 
inhibitory influence on the enzyme α-amino levuli-
nate dehydratase that influenced heme synthesis [60]. 
Renal toxicity arises in two ways, either by reversible 
commonly discovered after serious exposure of lead 
acetate in children or by irreversible interstitial 
nephropathy usually noticed during long-term expo-
sure to lead [60]. Histopathological changes in the 
renal proximal tubular epithelium were derived from 
lead toxicity, and these changes cause interstitial 
nephritis and usually related to hypertension. It accu-
mulated in proximal involuted tubules of renal cortex 
that produce both biochemical and morphological evi-
dence of lead toxicity. An extensive work to study the 
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severe effects of lead toxicity toward the kidneys has 
been well-documented [61]. Another trigger for 
lead-induced renal toxicity is from the exposure 
toward environmental lead poisoning and fast becom-
ing an increased health burden to both animals and 
humans [62]. In this exposure, an acute lead-induced 
renal damage can occur in the absence of acute intox-
ication so that occult lead nephropathy may not be 
recognized as such [62]. While in chronic accumula-
tion of lead in the body eventually leads to impairment 
in renal function [63]. Urea and creatinine are a waste 
product of amino acid metabolism they removed by 
kidney [64]. Oxidative stress appears to be involved in 
the development of renal toxicity induced by the envi-
ronmental lead exposure that causes significant patho-
logical lesions on the renal systems of men and ani-
mals [65]. Conterato et al. [66] investigated blood 
levels of Pb and Cd and parameters of oxidative stress 
in battery-manufacturing workers, painters from an 
automotive industry and workers who were not occu-
pationally exposed to these metals, who served as 
controls. Although MDA levels were not increased in 
the exposed groups, elevated activity of GST was 
observed in both battery-manufacturing workers and 
painters. The correlation analyses revealed that Pb and 
Cd contribute to the elevation of this enzyme activity 
that was explained by the ability of these metals to 
induce GST gene expression. On the other hand, the 
increased GPx and SOD activities, observed only in 
the battery manufacturing workers, correlates with the 
increased of Pb blood levels, while CAT activity, 
changed only in painters, inversely correlated to Cd 
blood levels. These changes suggest an additive effect 
of Cd and Pb on blood GST levels, while other alter-
ations in oxidative stress parameters were distinc-
tively associated with either Pb or Cd blood levels. 
Hence, there may be a lack of interaction between Pb 
and Cd on the level of oxidative status in blood after 
coexposure by inhalation. Another investigation with 
the results supporting the possible antagonism between 
Pb and Cd was carried out on bank voles, animals that 
served as a good model for environmental lead expo-
sure. Animals were exposed for 6 weeks of dietary Cd 
and Pb (Cd-60; Pb-300; Cd-60 + Pb-300 μg/g dry 
weight-concentrations two-fold higher than those 
expected in high contaminated areas). No significant 
changes in the liver concentrations of toxic metals, 
TBARS or GSH levels were observed between groups 
treated with a single metal and a group treated with a 
mixture [67,68] administered to rats by gavage for 
90 days, three different doses, in an equitoxic mixture 
ratio, where the highest dose was 1/10 of the previ-
ously established LD50 for a mixture of Pb nitrate and 
Cd-chloride. Results indicated a strong, significant 
increase in MDA and decrease in GSH content in the 
liver and kidneys with decreased activities of antioxi-
dant enzymes SOD, CAT, GPx. However, this experi-
mental study did not give the information on the indi-
vidual effects of Cd or Pb treatment under the same 
experimental conditions, and therefore, it is difficult 
to discuss possible interactions between these metals. 
In the same experiment, MT-1 and MT-2 gene expres-
sions were investigated in rat liver and renal cortex 
and their significant up-regulation in both liver and 
kidneys were shown. The activation of defense sys-
tems was explained by the antioxidant effect of MT, 
availability of cysteine in MT for GSH synthesis, and 
by MT mRNA transcriptional response triggered by 
ROS. They also speculated that these changes could 
be related to the inhibition of steroid organic enzyme 
activity and effects on testosterone levels, sperm count 
and motility after coexposure to Pb and Cd. Literature 
data indicate that, similarly to Cd or Pb exposure, 
coexposure to these toxic metals induces apoptosis. In 
a 90-day subchronic oral toxicity study, relatively low 
and environmentally realistic concentrations of lead 
and cadmium induced significant hepatic and renal 
apoptosis that consequently impaired their func-
tion [69]. Pb hepatotoxicity has been related to the ele-
vation in the levels of serum liver enzymes AST, ALT, 
and ALP [70] and alterations in hepatic cholesterol 
metabolism [71]. Due to its specific role in the organ-
ism, the liver is, besides blood, the main target of 
Pb-induced oxidative stress. Acute IP administration 
of 15 mg Pb-acetate/kg BW for 7 days [72] and 25 mg 
Pb-acetate/kg BW for 5 days [71] induced decreased 
in SOD and CAT activity and a two-fold decrease in 
GPx activity. These changes were followed by a sig-
nificant decrease in the levels of GSH, partly as a 
result of biliary excretion of Pb bound to the SH 
groups of GSH, as proposed by Abdou and Hassan [71]. 
Investigation of the recovery from Pb-induced oxida-
tive stress in the rat liver was undertaken by 
Omobowale et al. [70]. Animals were given 0.25, 0.5, 
and 1.0 mg Pb-acetate/mL for 6 weeks and then were 
not treated for another 6 weeks. Increase in liver func-
tion test parameters, ALT, AST, ALP, as well as MDA 
and H2O2 concentrations in liver, and decrease in anti-
oxidant enzymes SOD, CAT, GPx, GST activity and 
the content of GSH were observed after 6 weeks of Pb 
treatment. At the end of the experiment, only SOD 
activity was recovered and was within the accepted 
range, pointing to incomplete recovery from the 
effects of Pb-induced oxidative stress on other 
enzymes. The most important impact of Pb-induced 
oxidative stress in the liver is lipid peroxidation [70] 
that causes the alteration of membrane integrity and 
fatty acid composition and is associated with the 
increase of MDA level in the liver [73]. In another 
experiment, with the objective to investigate the gen-
der, dose and time-dependent manner of Pb-induced 
oxidative stress besides observing time and dose-de-
pendent increase in liver MDA levels; the correlation 
between oxidative stress, apoptosis, and mitogen-acti-
vated protein kinases (MAPKs) in hepatocytes was 
observed. The authors concluded that apoptosis might 
be induced via oxidative stress-mediated alterations in 
MAPKs [74]. Kilikdar et al. [75] stated that when the 
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rats received lead acetate at a dose of 15 mg/kg BW IP 
and showed significantly increased in ALP activity by 
62% in comparison to the activity measured in control 
animals, and rats when treated with lead acetate for 
7 consecutive days. From the same study, a significant 
increase in the level of serum bilirubin by 38% in 
comparison to the values obtained in the control rats 
was also documented. There was no significant differ-
ence when compared to the control group in serum 
activities of LDH, ALP, ALT, AST while glycemia 
was slightly higher in rats exposed to 0.3% PbAc, but 
albumin and levels of TP were lower in all groups 
treated with lead [76].
Mice injected IP with lead acetate at a dose of 
10 mg/kg showed a mild significant elevation of serum 
ALT only after 24 h (p<0.05) while at 100 mg/kg, 
it causes a significant time-dependent increases in 
serum ALT (p<0.001), when compared to the control 
group [77].
Lead Effects on Neurobehavioral
The neurotoxicity of lead at high level of expo-
sure has been well-documented for both man and 
animal species. Both the peripheral and the central 
nervous system are influenced by lead exposure. In 
children, the central nervous system is more influ-
enced whereas, in adults, it is more on the peripheral 
nervous system [78]. Encephalopathy (an advanced 
degeneration of some parts of the brain) is a condition 
manifested significantly when comes into contact with 
lead, and the main symptoms include hallucinations, 
irritability, poor attention span, dullness, memory loss, 
muscular tremor, and headache. At high exposures, 
much simpler appearances arised and this includes 
paralysis, delirium, coma, convulsions, ataxia, and 
lack of coordination [79]. However, young children as 
well as unborn young are particularly vulnerable to the 
neurological influences cause by lead intoxication as 
the developed nervous system absorbs more portion of 
lead. Compared to adults, the amount of lead which is 
systemically circulating having contact to the children 
brain is meaningfully advanced [80]. Children might 
be hyperactive, easily irritated, and non-attentive even 
at the low level of exposure to lead. Nevertheless, 
children with higher levels of lead intoxication might 
have decreased intelligence, delayed growth, hearing 
loss and possessing only short-term memory ability. 
Permanent brain damage and even death might be a 
result of higher exposure to lead [81]. Some evidence 
is signifying that IQs with attentiveness, behavior of 
the child and concentration ability are influenced the 
low level of lead exposure significantly. An impact of 
exposure of lead to the peripheral nervous system was 
detected in a form of peripheral neuropathy, including 
decreased motor activity due to loss of myelin sheath 
that isolates the nerves, therefore totally damaging the 
nerve impulses transduction, resulting in deficiency 
of muscular coordination, fatigue and muscular weak-
ness, particularly of the exterior muscles [82]. As 
stated by Mustafa and Hussein [83], administration of 
lead acetate to four rats from the group that showed 
many negative neurological signals, however, such as 
a decrease in vitality; muscle-mass weakness; trem-
ors, along with lack of stability and equilibrium; an 
abnormal gait. One critical event during astrocyte dif-
ferentiation is the change in the expression of the glial 
marker called glial fibrillary acidic protein [84]. Lead 
acetate can be found stored in the cerebellum, disturb-
ing its physiology as well as causing neurotoxicity, 
cellular deterioration, and possibly cellular death [85].
Lead Effects on the Hematopoietic System
Hematological influences were verified in ani-
mals and humans after lead exposure. These influ-
ences contain urinary porphyrins raised levels, 
δ-ALA, coproporphyrins, erythrocyte protoporphyrin, 
and zinc protoporphyrin. The results are the outcome 
of the three enzymes alteration, which involved in the 
biosynthesis of heme: δ-aminolevulinic dehydrase, 
ferrochelatase, and δ-ALA synthetase (ALAS) [17].
The hematopoietic system would be directly affected 
by lead by restraining the hemoglobin (Hb) synthe-
sis through prevention of several key enzymes, which 
are parts of the pathway of heme synthesis. Yet, it 
decreases the circulating erythrocytes life span via 
raising the cell membranes fragility. Hence, anemia 
would be the result of the joint outcome of these two 
processes [51]. Lead has toxic effects in a wide variety 
of organs, causing impairments in the nervous, hema-
topoietic, renal, cardiovascular and reproductive sys-
tems following ingestion, inhalation or skin absorp-
tion [51]. There are two types of anemia resulted from 
lead poisoning: Frank anemia, that only occurred 
when the level of lead in blood is significantly raised 
for an extended period of time and hemolytic anemia, 
that is related to a seriously high level of exposure to 
lead [86]. The heme synthesis pathway suggestively 
affected by lead in a manner of dose-dependent via 
three main enzymes down-regulating that is included 
in the synthesis of the heme; the mitochondrial enzyme 
ferrochelatase that catalyzed the insertion of iron to 
protoporphyrin in order for the heme to be formed, 
δ-ALAD, the cytosolic enzyme by which the forma-
tion of porphobilinogen from δ-ALA is catalyzed, and 
finally, ALAS, a mitochondrial enzyme by which the 
formation of ALA is catalyzed [87].
Oxidative stress was understandably the major 
mechanism of lead toxicity. One of the main effects 
of lead toxicity in the hematopoietic system involves 
impairment of the Hb synthesis pathway through dis-
rupted expression of genes encoding δ-ALAD, ferro-
chelatase, and ALAS [87]. In the mitochondria, the 
final steps, as well as the initial steps, of the synthesis 
of heme occur, while the intermediate steps occur in 
the cytoplasm. Yet, the three vital enzymes of this path-
way, which have been mentioned above, inhibited by 
lead but confined only for clinical use to measure the 
degree of lead poisoning and its influence on ALAD 
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is higher. Accumulation of ALA leads to restriction 
of ALAD, noticeable in the urine and plasma even 
at level of <10 μg/dl of lead in blood. While ALAD 
inhibition is known earlier at 10-20 μg/dl of lead lev-
els in blood, biosynthesis of heme does not reduce 
till the action of ALAD is restricted by 80-90% that 
takes place at a higher concentration of lead of about 
55 μg/dl in blood [88].
Ferrochelatase inhibition resulted in accumu-
lation of protoporphyrin in erythrocytes and raised 
secretion of coproporphyrin in urine. Furthermore, 
restriction of this enzyme resulted when iron is sub-
stituted by zinc in the ring of porphyrin to form zinc 
protoporphyrin (ZPP). ZPP concentration therefore 
rose, and this could be used as a signal for monitoring 
the level of exposure by lead [89]. Hence, the produc-
tion of heme is blocked by the cooperative restriction 
of those three key enzymes by the synthesis pathway 
of heme. The responsible mechanism for the short-
ening of erythrocytes life cycle was not established 
well. However, one of the most basic hematological 
influences observed from lead poisoning showed 
basophilic stippling’s of red cells in blood (existence 
of dense material in red cells of blood), that can be a 
possible biomarker to established poisoning by lead. 
Those collections are the products of ribonucleic acid 
degradation [21]. Kilikdar et al. [75] stated when rats 
were treated with LA IP for 7 consecutive days; the 
Hb content of blood significantly decreased by 25% 
in comparison to the value observed in the control 
rats. Erythrocytes are considered as the most vulner-
able cells toward oxidative stress from lead as they 
have very limited reservoirs of antioxidant enzymes to 
counter the effect of ROS. In addition, they are unable 
to replenish antioxidant enzymes because they lack 
rough endoplasmic reticulum and becoming much 
prone to the damage by ROS. A number of red cells 
are used to indicate anemia produced by lead intoxi-
cation [90]. Lead toxicity also contributes toward the 
reduction of total Hb, red blood cells (RBCs) count 
and also the plasma level of T3 and T4 without signifi-
cant changes for white blood cells (WBCs) count [91]. 
This finding was supported by Ibrahim et al. [92] in 
which it states that lead acetate when given orally to 
female rats at a dose of 10 mg/kg BW revealed signif-
icant decrease in Hb concentration, mean corpuscular 
Hb concentration, RBC count, and packed cell vol-
ume, whereas showed significantly increase the per-
centage of monocyte and mean corpuscular volume, 
total proteins, and WBC count.
Lead Effect on Bone
In the human body, bones are the primary loca-
tion for the storage of lead [93]. Lead is supposed to 
be stored in two sections in the bones. The non-ex-
changeable pool present deep in the bone cortex and 
the exchangeable pool located at the bone surface. 
As lead may get access to plasma easily from the 
exchangeable pool, it is actively being re-absorbed, it 
could transfer to the surface after leaving the non-ex-
changeable pool [21]. In adults, isotope procedure 
for stable lead revealed that bones contribute nearly 
40-70% of the discharged lead in the blood. Around 
85-95% of lead is stored in adults’ bones, while in chil-
dren; about 70% of lead in a high concentration was 
detected in soft tissues. Lead mobilization and storage 
in bones rest on a number of factors such as age, dose/
rate of pregnancy, exposure to lead, race, and gesta-
tion. Al Naimi et al. [94] stated that administration of 
lead acetate at 75 mg/kg BW at 20 and 40 days cause 
moderate hyperplasia of hemopoietic tissue with pro-
liferation of megakaryocytes and the presence of thin 
trabeculae of calcified cartilage covered by a thin 
layer of bone. The bars of mineralized cartilage which 
resulted from impaired resorption of osteoclasts are 
wide and project further into the metaphyseal marrow 
cavity as compared to normal healthy bones.
Lead Effect on Reproductive System
Elgawish and Abdelrazek [30] stated that lead 
acetate caused a significant decrease in functions of 
male reproductive organs as well as the occurrence of 
testicular tissue alterations in the histological patterns 
of testis. Samples of semen and blood have been ana-
lyzed from workers of factory manufacturing batteries 
and showing an opposite association between sperm 
concentration and volume and lead level in plasma. 
Important associations have been observed between 
the levels of protoporphyrin, dehydratase, and lead 
and reproductive parameters, exhibiting a reduction in 
the motility and density of sperm and viability counts 
and increased in the morphology of abnormal sperm 
head [95]. In both women and men, adverse effects 
on the reproductive system are due to the effect of 
lead. General effects found in men include: Abnormal 
spermatogenesis (decreased number and motility), 
reduced libido, abnormal prostatic function, chro-
mosomal damage, changes in serum testosterone and 
infertility. In women, lead toxicity is more subjected 
to miscarriage, pregnancy hypertension, infertility, 
premature membrane rupture, premature delivery and 
pre-eclampsia [12]. Furthermore, direct effect of lead 
on the progressive stages of the fetus was also studied 
during the gestation period [96]. Experimental find-
ings revealed that animals exposed to lead exhibited 
lower levels of plasma luteinizing hormone (LH) 
after stimulation with gonadotropin-releasing hor-
mone as compared to controls as well as reduction in 
inhibin/follicle-stimulating hormone (FSH) ratio [97]. 
The rats treated with lead at a dose of 30 mg/kg BW 
presented considerable decrease in T3, T4 and TSH 
levels in serum, and histopathological findings exhib-
ited an enlarged thyroid follicles associated with flat-
tened epithelium as compared with negative control 
animals [98]. Saleh et al. [99] stated that there is an 
important reduction in the mating index and fertility 
index in females that were mated with lead-exposed 
male. Lead-exposed rats managed with testosterone 
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took a less start-time to impregnate females. Marginal 
rise in number of implantations and decrease in 
pre- and post-implantation loss in females mated with 
rats coadministered with lead and testosterone indi-
cates increased in fertility efficiency. Nevertheless, 
no important improvement in fertility was detected in 
normal rats injected with testosterone alone compar-
ing to that of control rats [99]. Meanwhile, lead ace-
tate administered orally to adult male rats at exposure 
of 273 or 819 mg/L cause significant decrease in the 
weight of the reproductive organs, reduction in epi-
didymal sperm count, motile sperm, and viable sperm 
indicating a significant decreased in sperm production 
and deteriorated sperm quality and in serum testoster-
one levels in treated rats indicating a decreased ste-
roidogenesis [100]. Lead acetate administered orally 
to rats at a dose of 8 mg/kg BW showed a significant 
decrease (p<0.05) in the reproductive organs and 
some accessory gland and also showed effect on lev-
els of LH and testosterone hormone and sperm count 
accompanied by an increase (p<0.05) in mitotic index 
and percentage of abnormal sperm [101]. Hammed 
et al. [102] stated the exposure to lead acetate to rats 
orally at dose of 10 mg/kg BW showed a significant 
decrease effects in the level of LH and FSH when 
compared to the control group.
Molecular Mechanisms of Lead Toxicity
Oxidative stress which plays an important role 
in lead poisoning is caused by an imbalance in the 
production of free radicals and compromising the sys-
tem’s ability to readily detoxify the body of those radi-
als resulted in cellular damage [12]. It starts with the 
onset of oxidative stress that has been proposed occur-
ring in two simultaneous pathways; first, the gener-
ation of ROS such as hydro peroxides (HO2 
•), sin-
glet oxygen, and hydrogen peroxide (H2O2). Second, 
the depletion of natural-occurring-antioxidants 
reserves [103]. The body’s antioxidant enzymatic sys-
tem works to neutralize the ROS generation, with the 
cell’s most important enzyme which is the GSH. GSH 
is a tripeptide (containing sulfhydryl groups) found in 
mammalian tissues which destroy free radicals [104]. 
GSH exists in two forms; reduced (GSH) and oxi-
dized GSH dismutase (GSSG). In reduced state, GSH 
donates reducing equivalents (H+ + e–) from its thiol 
groups in cysteine residues to ROS, thus making them 
stable. After donating its electron, it then readily com-
bines with another molecule of its own to the form 
GSH disulfide (GSSG) in the presence of GPx. The 
reverse/opposite reaction generates GSH GSSG in the 
presence of GSH reductase (GR). Normally, only about 
10% of GSH exists in the oxidized form (GSSG), the 
rest exist in reduced form as GSH. However, GSSG 
concentration is much higher than that of GSH during 
oxidative stress.
Lead shows a strong electron sharing property 
which aids in the formation of covalent bonds. These 
covalent bonds are formed between the lead moiety 
and the sulfhydryl groups in the antioxidant enzymes, 
making the enzymes most susceptible targets for lead, 
eventually rendering them inactive. On the other hand, 
lead inactivates GSH by binding with its sulfhydryl. 
This process gives rise to the synthesis of GSH from 
cysteine via the γ-glutamyl cycle, but would normally 
not be effective enough to replenish the supply of 
GSH [105]. Furthermore, in addition, lead inactivates 
δ-ALAD, GR, GPx, and GSH-S-transferase enzymes, 
and further depresses the levels of GSH [7,8]. Others 
are; SOD and CAT. Decreased concentration of SOD 
reduces the clearance of superoxide radical, while 
reduced CAT impairs the superoxide radical (O2 
– •) 
scavenging. Lead is also able to replace the zinc ions 
which serve as important co-factors for these antioxi-
dant enzymes in trying to inactivate the enzymes [106], 
this is apart from targeting their sulfhydryl groups.
Lipid peroxidation is considered as a biomarker 
to oxidative stress and is one of the most investigated 
consequences of ROS on lipid membranes. The ROS 
takes electrons from the cell membranes and damages 
the cell by denaturing lipid that formed the membrane. 
Apart from lipid peroxidation, lead induces oxidation 
to Hb, resulting to hemolysis of the RBC. This hap-
pens due to ALAD inhibition and caused increased in 
the concentration of ALA substrate in blood, as well 
as urine. An elevated level of ALA, in turn, generates 
hydrogen peroxide and superoxide radical which goes 
to interact with oxy-Hb, resulting in the generation 
of hydroxyl radicals [21]. The aforementioned mech-
anism makes the cell highly vulnerable to oxidative 
stress and may also lead to cell death.
Bivalent cations such as Ca2+, Mg2+, Fe2+ and 
monovalent cations such as Na+, could also be sub-
stituted by Pb, thereby affecting various fundamen-
tal biological processes [107] in what is called as an 
ionic mechanism of lead action. Fundamental cellu-
lar processes such as intra and intercellular signaling, 
cell adhesion, protein folding and maturation, apop-
tosis, ionic transportation, enzyme regulation, release 
of neurotransmitters have been significantly affected 
by the aforementioned ionic mechanism [108]. This 
mechanism contributes principally to neurological 
deficits after lead replaces calcium ions; it becomes 
competent to cross the blood-brain barrier (BBB) at 
an appreciable rate. The lead then accumulates in 
astroglial cells (containing lead-binding proteins). 
The effects of lead toxicity are more pronounced in 
immature astroglial cells (developing nervous system) 
that lack lead-binding proteins. It (lead) easily dam-
ages the astroglial cells and obstructs the formation of 
myelin sheath, which is both involved in the develop-
ment of BBB.
Key neurotransmitters such as protein kinase C 
can be affected by such lead replacement of calcium 
as picomolar concentration, protein kinase C regulates 
long-term neural excitation, and memory storage. Lead 
also affects the sodium ion concentration, which is 
responsible for enormous biological activities that are 
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vital such as generation of action potentials in the excit-
atory tissues for the purpose of cell to cell communi-
cation, uptake of neurotransmitters (choline, dopamine, 
and GABA), and regulation of uptake and retention of 
calcium by synaptosomes. This interaction between lead 
and sodium seriously impairs the normal functioning of 
the aforementioned sodium-dependent processes [109].
Possible treatment
Treatment may not be successful if the dam-
age is too extensive particularly to the cells or tissue 
of the nervous system. Calcium disodium edentate 
(Ca-ethylenediaminetetraacetic acid [EDTA]) is given 
subcutaneous or intravenous for 3 days especially for 
cattle after lead exposure. A similar dose in dogs com-
partmentalized to 4 treatments/day given subcutane-
ously in combination with 5% dextrose for 2-5 days. 
If clinical signs persist, an extra 5-day treatment might 
be necessary after 1 week gap of stopping the ther-
apy. Currently, there is no appropriate veterinary prod-
uct that contains Ca-EDTA available commercially. 
Tissue deposition of lead is decreased by thiamine, 
which can also lessen the clinical manifestations. The 
most useful response seems to be resulted from com-
bining thiamine and Ca-EDTA treatment [110]. The 
chelating agent succorer (meso 2, 3-dimercaptosuc-
cinic acid [DMSA]) has been confirmed to be useful 
in birds and also efficient in dogs. DMSA has a much 
lesser side effects as compared to Ca-EDTA [111]. 
Cathartics such as a rumenotomy magnesium sulfate 
might be useful in removing lead from the GI tract. 
Tranquilizers or barbiturates could be used as a sup-
portive therapy for cases manifested with convulsion 
episodes [110]. Antioxidant treatment combined with 
chelating agent might reduce the oxidative damage 
related to severe lead poisoning. However, antioxi-
dants like N-acetylcysteine have been used in combi-
nation with DMSA [111]. In chelonian, it is possible to 
remove the ingested lead fragments from the stomach 
using endoscopically-guided forceps. This should be 
followed with 2 weeks therapy with Ca-EDTA [110].
Conclusion
Lead poisoning has been known to humankind 
since centuries ago and became apparent during the 
industrial revolutions in the 18th century. Lead has no 
recognized function biologically in the body, and thus 
when it enters the body, it causes serious health effects 
which might be permanent and lead to fatality.
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